CISEN(SH:603367) Zheng Quan Zhi Xing·2025-06-25 16:12Core Viewpoint - The announcement details the share pledge and release activities of major shareholder Han Yanzhen of Chenxin Pharmaceutical, indicating significant movements in shareholding and potential implications for the company's financial stability and investor confidence [1][2]. Shareholder Information - Han Yanzhen holds 31,977,829 shares, representing 7.06% of the total share capital of the company [1]. - After the release of 7,300,000 shares from pledge on June 20 and June 23, 2025, Han Yanzhen has 14,120,000 shares remaining pledged, which is 66.51% of his total holdings [1][2]. Pledge and Release Details - The total number of shares released from pledge is 7,300,000, accounting for 1.61% of the company's total share capital [1]. - The remaining pledged shares represent 3.12% of the company's total share capital [1]. Future Pledge Plans - On June 24, 2025, Han Yanzhen initiated a new pledge of shares, with the pledged amount being 7,150,000 shares, set to mature on June 24, 2026 [1]. - The new pledge represents 22.36% of Han Yanzhen's total holdings [1]. Cumulative Pledge Situation - The cumulative pledged shares by Han Yanzhen and his action-in-concert party, Nanjing Chenxin Tongtai Venture Capital Co., Ltd., total 33,346,115 shares, which is 7.36% of the company's total share capital [2].